SCHEMBL573582

SCHEMBL573582

C1COC(C2COCCO2)CO1

nearest known ligand 0.37

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.37
CHRM4 P08173 1/20 0.37
CHRM5 P08912 1/20 0.37
CHRM3 P20309 1/20 0.37
TTR P02766 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29742575 1.00 CHRM2 (0.37) CHRM2CHRM4CHRM5CHRM3TTR
Hydrochloric Acid SCHEMBL25245581 0.97 CHRM2 (0.36) CHRM2CHRM4CHRM5CHRM3TTR
SCHEMBL29023882 0.97
SCHEMBL28436926 0.97 TTR (0.40) CHRM2CHRM4CHRM5CHRM3TTR
SCHEMBL16878490 0.94
SCHEMBL18885585 0.91 CHRM2 (0.33) CHRM2CHRM4CHRM5CHRM3
SCHEMBL7274558 0.89
SCHEMBL16878223 0.88 CHRM2 (0.32) CHRM2CHRM4CHRM5CHRM3
SCHEMBL7268795 0.84
SCHEMBL15824288 0.84 CHRM2 (0.33) CHRM2CHRM4CHRM5CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 404 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023116882-A1 PHARMACEUTICALLY ACCEPTABLE SALT AND CRYSTALLINE FORM OF GLP-1 RECEPTOR AGONIST AND PREPARATION METHOD THEREFOR 江苏恒瑞医药股份有限公司 2023-06-29 WO claimed
CN-115433167-A Benzo-heterocyclic compound with Snail inhibitory activity, preparation method, pharmaceutical composition and medical application thereof 中国药科大学 2022-12-06 CN claimed
WO-2021132858-A1 METHOD FOR MANUFACTURING BIODEGRADABLE POLYMER MICROPARTICLES FOR FILLER, AND METHOD FOR MANUFACTURING INJECTION COMPRISING SAME 주식회사 울트라브이 2021-07-01 WO claimed
CN-108503574-A A method of synthesis 3- vinyl -4- acetenyl -2,3- dihydro pyrrole derivates 山东理工大学 2018-09-07 CN claimed
CN-107556422-A Prepare P (VDF DB) g S C3H6‑SO3The method of H proton exchange membrane materials 西安交通大学 2018-01-09 CN claimed
CN-105080604-B A kind of crosslinked polystyrene microsphere surface synthesis and the preparation method of immobilized N hydroxyphthalimides catalyst 中北大学 2017-09-05 CN claimed
CN-105080604-A Preparation method of crosslinked polystyrene microsphere surface synthesized and immobilized N-hydroxyphthalimide catalyst UNIV NORTH CHINA 2015-11-25 CN claimed
CN-102516564-B Soap-free preparation method of biodegradable polymer nanoparticles UNIV HUAZHONG SCIENCE TECH 2014-03-26 CN claimed
CN-103285922-A Epoxy polymer microsphere immobilized tetramethyl-piperidyl-nitroxide free radical catalyst, as well as preparation method and application method thereof UNIV NORTH CHINA 2013-09-11 CN claimed
CN-102516564-A Soap-free preparation method of biodegradable polymer nanoparticles UNIV HUAZHONG SCIENCE TECH 2012-06-27 CN claimed
CN-102399118-A Metal amino borane compound and application of derivative thereof in reduction reaction DALIAN CHEMICAL PHYSICS INST 2012-04-04 CN claimed
CN-101279956-B Matrix metalloprotease inhibitors and synthetic method thereof UNIV NANCHANG 2011-06-15 CN claimed
WO-2025235363-A1 CYCLIN-DEPENDENT KINASE 4 DEGRADERS BLUEPRINT MEDICINES CORPORATION (US) 2025-11-13 WO disclosed
US-20240239811-A1 5-(5-(PIPERIDIN-4-YL)THIENO[3,2-C]PYRAZOL-2-YL]INDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE T REMIX THERAPEUTICS INC. 2024-07-18 US disclosed
CN-118324778-A Fourth generation EGFR inhibitors 苏州共康医药科技有限公司 2024-07-12 CN disclosed
WO-2024140714-A1 WRN INHIBITOR 苏州浦合医药科技有限公司 2024-07-04 WO disclosed
EP-0030663-B1 LAYER-MODIFIED PARTICULATED FLUOROPOLYMERS AND PROCESS FOR THEIR PREPARATION HOECHST AKTIENGESELLSCHAFT (DE) 1983-10-12 EP disclosed
US-4391940-A POLYMERS/SHELL-CORE/ HOECHST AKTIENGESELLSCHAFT (DE) 1983-07-05 US disclosed
US-4331800-A CHAIN EXTENSION WITH A BIS/CYCLIC IMINOETHER TEIJIN LIMITED (JP) 1982-05-25 US disclosed
EP-0030663-A2 Layer-modified particulated fluoropolymers and process for their preparation HOECHST AKTIENGESELLSCHAFT (DE) 1981-06-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239811-A1 5-(5-(PIPERIDIN-4-YL)THIENO[3,2-C]PYRAZOL-2-YL]INDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE T HNRNPAB, HNRNPC, HNRNPA1 CHRM2 4862/4885CHRM4 4875/4885CHRM5 4799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.